- Home
- Equipment
- asia middle east
- microbiomes
Show results for
Refine by
Locations
- Asia & Middle East
- Afghanistan
- Armenia
- Azerbaijan
- Bahrain
- Bangladesh
- Bhutan
- Brunei Darussalam
- Cambodia
- China
- East Timor
- Georgia
- Guam
- India
- Indonesia
- Iran
- Iraq
- Israel
- Japan
- Jordan
- Kazakhstan
- Kuwait
- Kyrgyzstan
- Laos
- Lebanon
- Malaysia
- Maldives
- Mongolia
- Myanmar
- Nepal
- North Korea
- Oman
- Pakistan
- Palestinian Territories
- Philippines
- Qatar
- Russia
- Saudi Arabia
- Singapore
- South Korea
- Sri Lanka
- Syria
- Taiwan
- Tajikistan
- Thailand
- Turkmenistan
- United Arab Emirates
- Uzbekistan
- Vietnam
- Yemen
Microbiomes Equipment Supplied In Asia Middle East
5 equipment items found
Manufactured by:Moon (Guangzhou) Biotech Co.,Ltd based inHuangpu District, CHINA
From tremendous microbiome resources to precision microbe-based drug. Human microbiome is recognized as the central hub of human health and disease development and harbors tremendous microbe-based drugs for improving human health and treating diseases. MoonBiotech is moving to a clinical-stage biotech company focused on the development of innovative ...
Manufactured by:Moon (Guangzhou) Biotech Co.,Ltd based inHuangpu District, CHINA
The rapid population growth, the increasing shortage of natural resources, the continuous deterioration of the climate, the abuse of fertilizers and pesticides, and the increasingly healthy consumer demand all make traditional agriculture face severe challenges. To deal with this big problem, we focused on a group of inconspicuous but huge numbers of ...
Manufactured by:LISCure Biosciences Inc. based inSeongnam-si, SOUTH KOREA
LMT (LISCure Microbiology-based Technology) Platform Consists of the Therapeutic Screening Platform, Microbial Optimization Platform, and Microbiome Database ...
Manufactured by:JD Bioscience Inc. (JDB) based inBuk-gu, SOUTH KOREA
NASH, an advanced form of non-alcoholic fatty liver disease (NAFLD), can progress to liver fibrosis, cirrhosis, and hepatocellular carcinoma (HCC). Genetic factors, environmental factors, and microbiome alterations are mainly involved in disease progression. Experts estimated that 24% of U.S. adults have NAFLD and more than 6.5% of them have NASH (NIH report, 2021). 20~30% of ...
Manufactured by:BiomX based inNess Ziona, ISRAEL
We are developing BX005, a topical phage cocktail that targets Staphylococcus aureus (S. aureus), a bacteria associated with the manifestation of the disease. This program leverages know-how and capabilities acquired under our previous programs with regard to topical formulation and clinical testing. In preclinical in vitro studies, BX005 was shown to be active against over 90% of strains of S. ...